InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,166.40
(
0.51%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,089.11
(
0.13%
)
Post# of 14685
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jimmy667

Send PM Follow Ignore
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

jimmy667

Re: Paullee post# 13363

Monday, 02/15/2021 4:40:03 PM

Monday, February 15, 2021 4:40:03 PM

Post# of 14685
From reading the Quarterly reports I got it that a research firm (NSABP)is running the TNBC trial drug combination with Keytruda and Generex is paying that company. I could be wrong but read the first paragraph at the top of 44 of the 10Q filed Dec 21, 20. Generex total cost is about $2.1 mil and they have paid $500k so far. I am thinking NSABP is in control of that trial and Generex can neither slow it down or speed it up. All payments are made by Generex on a milestone basis to NSABP.
Patience on that one.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up